Thyroid hormone signaling causally influences pancreatic disease risk: Evidence from Mendelian randomization and multi-omics integration.
2/5 보강
TL;DR
Findings establish thyroid function as a causal determinant of pancreatitis susceptibility, identify cell type-specific mechanisms including local thyroid hormone inactivation and metabolic reprogramming, and demonstrate that patient-derived organoids better preserve prognostically favorable metabolic phenotypes than cell lines.
OpenAlex 토픽 ·
Pancreatitis Pathology and Treatment
Pancreatic and Hepatic Oncology Research
Genetic Associations and Epidemiology
Findings establish thyroid function as a causal determinant of pancreatitis susceptibility, identify cell type-specific mechanisms including local thyroid hormone inactivation and metabolic reprogramm
- p-value P = 0.0015
- 95% CI 0.17-0.80
APA
Xuejiao Wu, Zilin Yang (2026). Thyroid hormone signaling causally influences pancreatic disease risk: Evidence from Mendelian randomization and multi-omics integration.. Computational biology and chemistry, 122, 108897. https://doi.org/10.1016/j.compbiolchem.2026.108897
MLA
Xuejiao Wu, et al.. "Thyroid hormone signaling causally influences pancreatic disease risk: Evidence from Mendelian randomization and multi-omics integration.." Computational biology and chemistry, vol. 122, 2026, pp. 108897.
PMID
41564647 ↗
Abstract 한글 요약
The relationship between thyroid function and pancreatic disease has been observed clinically, yet causality remains unestablished. We applied bidirectional Mendelian randomization using genetic instruments from genome-wide association studies encompassing over 500,000 individuals to determine causal relationships. We demonstrate that genetic liability to hypothyroidism substantially protects against acute pancreatitis (odds ratio 0.37, 95 % CI 0.17-0.80). Genetically elevated basal metabolic rate increases acute pancreatitis risk (OR 1.16) while decreasing chronic pancreatitis risk (OR 0.77), revealing divergent pathophysiological mechanisms. No causal relationship exists between thyroid function and pancreatic cancer. To elucidate underlying mechanisms, we performed multi-omics analysis including bulk RNA sequencing from 172 pancreatic adenocarcinomas, single-cell RNA sequencing from acute pancreatitis (32,830 cells), chronic pancreatitis (30,426 cells), and pancreatic cancer (95,751 cells), and GeoMx spatial transcriptomics (253 regions). High metabolic gene expression predicts favorable cancer survival (hazard ratio 0.52, P = 0.0015). Single-cell analysis reveals myeloid-specific metabolic gene downregulation in chronic pancreatitis and 31-fold upregulation of the thyroid hormone-inactivating enzyme DIO3 in tumor epithelial cells. Spatial transcriptomics demonstrates that PPARGC1A downregulation occurs in preneoplastic lesions before malignant transformation. These findings establish thyroid function as a causal determinant of pancreatitis susceptibility, identify cell type-specific mechanisms including local thyroid hormone inactivation and metabolic reprogramming, and demonstrate that patient-derived organoids better preserve prognostically favorable metabolic phenotypes than cell lines. Thyroid function represents a potentially modifiable risk factor for inflammatory pancreatic disease.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Artificial Intelligence Models Integrating Preoperative Prostate MRI and Clinical Parameters for Predicting Extraprostatic Extension: A Systematic Review and Meta-Analysis.
- Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA.
- Development and validation of a predictive and prognostic model of perineural invasion in colorectal cancer.
- Host-microbe interactions in NAD metabolism.
- Interpretable Machine Learning Model for Predicting Prolonged Postoperative Length of Stay in Lung Cancer Patients Undergoing Day Surgery: A Retrospective Cohort Study.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.